ESR(01821.HK)擬根據20億美元多幣種債券發行計劃發行以新加坡元計值證券
格隆匯 2 月 23日丨ESR(01821.HK)發佈公吿,公司擬向亞洲及歐洲的機構投資者進行證券的國際發售。就建議證券發行而言,公司將向若干合資格機構投資者提供有關集團的企業及財務資料,該等資料此前不一定曾經對外公開。擔任聯席賬簿管理人的Credit Suisse (Singapore) Limited、DBS Bank Ltd.及United Overseas Bank Limited負責管理建議證券發行。
倘發行證券,集團擬將證券發行所得款項淨額用於為現有借款進行再融資、就集團將來可能尋求的潛在收購及投資機遇提供融資,以及集團營運資金要求及一般公司用途。公司將會向新交所提交證券在新交所正式名單上市及掛牌的申請。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.